UCSD has initiated a clinical trial to assess Nexalin Technology's Halo Clarity device for treating mTBI and PTSD.
For the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...
MyChesCo on MSN15h
FDA Takes Action on Allergies, Diabetes, Parkinson’s, and Deadly Food Safety Scare—What You Need to KnowThe U.S. Food and Drug Administration (FDA) has announced several significant developments this week, spanning advancements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback